RLAY

Relay Therapeutics, Inc. Common Stock

$14.05 +1.08%

Recent alerts on RLAY

All signals →

SEC filing RLAY Prices $12.00 Offering, Sells 26.35M Shares, Net $296.8M Proceeds

News Relay Therapeutics prices $275M public offering of common stock at $12/share

News Relay Therapeutics launches $175M public stock offering

Scanner Unusual buy pressure (2.5x avg, 60% up-volume, +10.8% / +1.30 intraday, above VWAP)

SEC filing RLAY Reports 60% Volumetric Response Rate, 89% Clinical Improvement in Zovegalisib Trial for Vascular Anomalies, Expansion Cohorts Opened

News Relay rises on mid-stage trial data for lead asset in vascular anomalies

News Why Relay Therapeutics Plummeted by Nearly 14% Today

News Expert Ratings For Relay Therapeutics - Benzinga

Failures to deliver 139,452 shares failed to deliver

Insider trade Sale by Thomas Catinazzo (Chief Financial Officer)

SEC filing RLAY Reports $642M Cash, FDA BTD for Zovegalisib in Breast Cancer, Phase 3 1L Trial 2027, RLY-8161 NRAS Trial Initiated

Insider trade Sale by Donald A Bergstrom (President, R&D)

Insider trade Sale by Peter Rahmer (Chief Corporate Development Officer)

Insider trade Sale by Thomas Catinazzo (Chief Financial Officer)

SEC filing RLAY Reports $12M Revenue, $0.08 EPS, +120% YoY, Announces $200M Buyback, Phase 3 Breast Cancer Trial 2027

Insider trade Sale by Thomas Catinazzo (Chief Financial Officer)

News Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.

SEC filing RLAY Announces $11.1M PFS Data, 43% ORR, FDA Breakthrough Therapy

Scanner Unusual buy pressure (3.4x avg, 71% up-volume, +5.7% / +0.55 intraday, above VWAP)

News Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29%

News Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million

Insider trade Sale by Donald A Bergstrom (President, R&D)

Insider trade Sale by Peter Rahmer (Chief Corporate Development Officer)

Insider trade Sale by Thomas Catinazzo (Chief Financial Officer)

News $207B Market Shift: The Race for Fast Track Approval in Oncology

Get push alerts for RLAY

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS